Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Apr 1997, 907-914, Vol 35, No. 4
J Kamerbeek, L Schouls, A Kolk, M van Agterveld, D van Soolingen, S Kuijper, A Bunschoten, H Molhuizen, R Shaw, M Goyal and J van Embden
Widespread use of DNA restriction fragment length polymorphism (RFLP) to
differentiate strains of Mycobacterium tuberculosis to monitor the
transmission of tuberculosis has been hampered by the need to culture this
slow-growing organism and by the level of technical sophistication needed
for RFLP typing. We have developed a simple method which allows
simultaneous detection and typing of M. tuberculosis in clinical specimens
and reduces the time between suspicion of the disease and typing from 1 or
several months to 1 or 3 days. The method is based on polymorphism of the
chromosomal DR locus, which contains a variable number of short direct
repeats interspersed with nonrepetitive spacers. The method is referred to
as spacer oligotyping or "spoligotyping" because it is based on
strain-dependent hybridization patterns of in vitro-amplified DNA with
multiple spacer oligonucleotides. Most of the clinical isolates tested
showed unique hybridization patterns, whereas outbreak strains shared the
same spoligotype. The types obtained from direct examination of clinical
samples were identical to those obtained by using DNA from cultured M.
tuberculosis. This novel preliminary study shows that the novel method may
be a useful tool for rapid disclosure of linked outbreak cases in a
community, in hospitals, or in other institutions and for monitoring of
transmission of multidrug- resistant M. tuberculosis. Unexpectedly,
spoligotyping was found to differentiate M. bovis from M. tuberculosis, a
distinction which is often difficult to make by traditional methods.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology
Research Laboratory for Infectious Diseases, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|